Form 8-K - Current report:
SEC Accession No. 0000950170-22-026551
Filing Date
2022-12-14
Accepted
2022-12-14 16:56:38
Documents
12
Period of Report
2022-12-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20221214.htm   iXBRL 8-K 52427
  Complete submission text file 0000950170-22-026551.txt   172974

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bolt-20221214_lab.xml EX-101.LAB 14018
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bolt-20221214.xsd EX-101.SCH 2454
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bolt-20221214_pre.xml EX-101.PRE 10277
6 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20221214_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 221462796
SIC: 2834 Pharmaceutical Preparations